We are live on ! Find out more
HSTO

Histogen Inc. Common Stock

Delisted

HSTO was delisted on the 4th of October, 2023.

36 hedge funds and large institutions have $37.8M invested in Histogen Inc. Common Stock in 2013 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

40% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 10

6% more funds holding

Funds holding: 3436 (+2)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

17% less capital invested

Capital invested by funds: $45.5M → $37.8M (-$7.69M)

Holders
36
Holders Change
+2
Holders Change %
+5.88%
% of All Funds
1.04%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
4
Increased
14
Reduced
10
Closed
2
Calls
Puts
Net Calls
Net Calls Change

HSTO Hedge Fund Activity: Q4 2013 in Review

36 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q4 2013, worth a combined $37.8M — down 17% from $45.5M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new HSTO positions and 2 closed out — a net gain of 2 holders — while 14 added to existing stakes and 10 trimmed.

The largest buyer was Polar Capital, adding an estimated $1.36M. The largest seller was Weiss Multi-Strategy Advisers, cutting an estimated $359K.

  • 36 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q4 2013, up from 34 in Q3 2013.
  • Funds reported $37.8M of Histogen Inc. Common Stock stock for Q4 2013, down 17% quarter-over-quarter.
  • 4 funds opened new Histogen Inc. Common Stock positions in Q4 2013 and 2 closed out, a net change of +2 holders.
  • The largest Histogen Inc. Common Stock buyer in Q4 2013 was Polar Capital, an estimated $1.36M added.
  • The largest Histogen Inc. Common Stock seller in Q4 2013 was Weiss Multi-Strategy Advisers, an estimated $359K sold.

Based on aggregated 13F filings for Q4 2013.